TOPIRAMATE AND THE RISK OF UROLITHIASIS

作者: Vishwanath S. Hanchanale , Chandra Shekhar Biyani , Anthony J. Browning , Adrian D. Joyce

DOI: 10.1111/J.1464-410X.2010.09953.X

关键词:

摘要:

参考文章(26)
Danilo Arnone, Review of the use of Topiramate for treatment of psychiatric disorders Annals of General Psychiatry. ,vol. 4, pp. 5- 5 ,(2005) , 10.1186/1744-859X-4-5
Edward Faught Jr, Topiramate in the treatment of partial and generalized epilepsy. Neuropsychiatric Disease and Treatment. ,vol. 3, pp. 811- 821 ,(2008) , 10.2147/NDT.S512
Stephanie Natsch, Yechiel A. Hekster, Antoine Keyser, Charles L.P. Deckers, Harry Meinardi, Willy O. Renier, Newer Anticonvulsant Drugs Drug Safety. ,vol. 17, pp. 228- 240 ,(1997) , 10.2165/00002018-199717040-00003
Ramsay L. Kuo, Michael E. Moran, Dennis H. Kim, Harrison M. Abrahams, Mark D. White, James E. Lingeman, Topiramate-induced nephrolithiasis. Journal of Endourology. ,vol. 16, pp. 229- 231 ,(2002) , 10.1089/089277902753752188
Eric H. Kossoff, Paula L. Pyzik, Susan L. Furth, Heather D. Hladky, John M. Freeman, Eileen P. G. Vining, Kidney Stones, Carbonic Anhydrase Inhibitors, and the Ketogenic Diet Epilepsia. ,vol. 43, pp. 1168- 1171 ,(2002) , 10.1046/J.1528-1157.2002.11302.X
William E. Rosenfeld, Topiramate: a review of preclinical, pharmacokinetic, and clinical data Clinical Therapeutics. ,vol. 19, pp. 1294- 1308 ,(1997) , 10.1016/S0149-2918(97)80006-9
Nasir Mirza, Anthony G. Marson, Munir Pirmohamed, Effect of topiramate on acid–base balance: extent, mechanism and effects British Journal of Clinical Pharmacology. ,vol. 68, pp. 655- 661 ,(2009) , 10.1111/J.1365-2125.2009.03521.X
Brian J. Welch, Dion Graybeal, Orson W. Moe, Naim M. Maalouf, Khashayar Sakhaee, Biochemical and Stone-Risk Profiles With Topiramate Treatment American Journal of Kidney Diseases. ,vol. 48, pp. 555- 563 ,(2006) , 10.1053/J.AJKD.2006.07.003
Rajesh C. Sachdeo, Topiramate. Clinical profile in epilepsy. Clinical Pharmacokinectics. ,vol. 34, pp. 335- 346 ,(1998) , 10.2165/00003088-199834050-00001